5SJN
Crystal Structure of human phosphodiesterase 10 in complex with 6,8-dichloro-2-[2-(6,7-dimethyl-1H-benzimidazol-2-yl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyridine
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X10SA |
Synchrotron site | SLS |
Beamline | X10SA |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2012-09-07 |
Detector | PSI PILATUS 6M |
Wavelength(s) | 0.999940 |
Spacegroup name | H 3 |
Unit cell lengths | 135.272, 135.272, 235.070 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 43.630 - 2.050 |
R-factor | 0.1852 |
Rwork | 0.183 |
R-free | 0.22650 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | inhouse model |
RMSD bond length | 0.012 |
RMSD bond angle | 1.484 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | REFMAC (5.7.0027) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 43.630 | 43.630 | 2.100 |
High resolution limit [Å] | 2.050 | 9.170 | 2.050 |
Rmerge | 0.079 | 0.018 | 1.501 |
Rmeas | 0.094 | 0.020 | 1.670 |
Total number of observations | 521602 | ||
Number of reflections | 100505 | 1115 | 7447 |
<I/σ(I)> | 12.62 | 64.52 | 1.18 |
Completeness [%] | 99.9 | 99.1 | 99.9 |
Redundancy | 5.2 | 5.091 | 5.229 |
CC(1/2) | 0.999 | 1.000 | 0.434 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 295 | 5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2 |